Researchers conducted a small, early-stage study to see if a type of focused radiation therapy could help patients with liver cancer who also have advanced liver scarring (cirrhosis) and are waiting for a liver transplant. The study involved just 9 patients. The radiation treatment, called stereotactic body radiation therapy (SBRT), was aimed at controlling the single liver tumor as a 'bridge' to keep patients eligible for transplant.
After about a year, 6 out of the 9 patients (67%) had either received a transplant or were still considered eligible for one. The treatment successfully controlled the targeted tumor in all patients, and no patients saw their cancer spread within or outside the liver during the study period. However, one patient (11%) experienced severe, grade 4 liver toxicity, which included liver failure, shortly after the radiation treatment.
It is very important to be cautious about these results. This was a very small pilot study with no comparison group, so we cannot say if the outcomes were due to the radiation or other factors. The occurrence of serious liver damage in one patient highlights a potential risk, especially for people with already weakened livers. For now, this research is a first step to see if this approach is worth studying in larger, more definitive trials.